BMJ Best Practice

参考文献

关键文献

Rowe PJ, Comhaire FH, Hargreave TB, et al. WHO manual for the standardized investigation and diagnosis of the infertile male. Cambridge, UK: Cambridge University Press; 2004.

Sharlip ID, Jarow JP, Belker AM, et al. Best practice policies for male infertility. Fertil Steril. 2002;77:873-882.

Huynh T, Mollard R, Trounson A. Selected genetic factors associated with male infertility. Hum Reprod Update. 2002;8:183-198.

Loren AW, Mangu PB, Beck LN, et al; American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500-2510.

Redmon JB, Carey P, Pryor JL. Varicocele - the most common cause of male factor infertility? Hum Reprod Update. 2002;8:53-58.

Liu PY, Handelsman DJ. The present and future state of hormonal treatment for male infertility. Hum Reprod Update. 2003;9:9-23.

Kroese AC, de Lange NM, et al. Surgery or embolization for varicoceles in subfertile men. Cochrane Database Syst Rev. 2012;10:CD000479.

参考文章

1.  Rowe PJ, Comhaire FH, Hargreave TB, et al. WHO manual for the standardized investigation and diagnosis of the infertile male. Cambridge, UK: Cambridge University Press; 2004.

2.  European Association of Urology. Guidelines on male infertility. 2015. http://www.uroweb.org (last accessed 28 October 2016)

3.  Sharlip ID, Jarow JP, Belker AM, et al. Best practice policies for male infertility. Fertil Steril. 2002;77:873-882.

4.  Jensen TK, Andersson AM, Jorgensen N, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril. 2004;82:863-870.

5.  Storgaard L, Bonde JP, Olsen J. Male reproductive disorders in humans and prenatal indicators of estrogen exposure: a review of published epidemiological studies. Reprod Toxicol. 2006;21:4-15.

6.  Isidori A, Latini M, Romanelli F. Treatment of male infertility. Contraception. 2005;72:314-318.

7.  Patki P, Woodhouse J, Hamid R, et al. Effects of spinal cord injury on semen parameters. J Spinal Cord Med. 2008;31:27-32.

8.  Shefi S, Turek PJ. Definition and current evaluation of subfertile men. Int Braz J Urol. 2006;32:385-397.

9.  Cherry N, Labreche F, Collins J, et al. Occupational exposure to solvents and male infertility. Occup Environ Med. 2001;58:635-640.

10.  Kunzle R, Mueller MD, Hanggi W, et al. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril. 2003;79:287-291.

11.  Huynh T, Mollard R, Trounson A. Selected genetic factors associated with male infertility. Hum Reprod Update. 2002;8:183-198.

12.  Lanfranco F, Kamischke A, Zitzmann M, et al. Klinefelter's syndrome. Lancet. 2004;364:273-283.

13.  Arap MA, Vicentini FC, Cocuzza M, et al. Late hormonal levels, semen parameters and presence of antisperm antibodies in patients treated for testicular torsion. J Androl. 2007;28:528-532.

14.  Evers JL, Collins JA. Assessment of efficacy of varicocele repair for male subfertility: a systematic review. Lancet. 2003;361:1849-1852.

15.  Trussell JC, Lee PA. The relationship of cryptorchidism to fertility. Curr Urol Rep. 2004;5:142-148.

16.  Loren AW, Mangu PB, Beck LN, et al; American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500-2510.

17.  Choi JM, Chung P, Veeck L, et al. AZF microdeletions of the Y chromosome and in vitro fertilization outcome. Fertil Steril. 2004;81:337-341.

18.  Hammoud AO, Gibson M, Peterson CM, et al. Impact of male obesity on infertility: a critical review of the current literature. Fertil Steril. 2008;90:897-904.

19.  Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231-245.

20.  Van Assche E, Bonduelle M, Tournaye H, et al. Cytogenics of infertile men. Hum Reprod. 1996;11(suppl 4):1-24.

21.  Jarow J, Sigman M, Kolettis PN, et al; American Urological Association. The evaluation of the azoospermic male: AUA best practice statement. 2010. http://www.auanet.org (last accessed 28 October 2016).

22.  Sigman M, Jarow JP. Endocrine evaluation of infertile men. Urology. 1997;50:659-664.

23.  Schoor RA, Elhanbly S, Niederberger CS, et al. The role of testicular biopsy in the modern management of male infertility. J Urol. 2002;167:197-200.

24.  Redmon JB, Carey P, Pryor JL. Varicocele - the most common cause of male factor infertility? Hum Reprod Update. 2002;8:53-58.

25.  Castilla JA, Zamora S, Gonzalvo MC, et al. Sperm chromatin structure assay and classical semen parameters: systematic review. Reprod Biomed Online. 2010;20:114-124.

26.  Zini A, Sigman M. Are tests of sperm DNA damage clinically useful? Pros and cons. J Androl. 2009;30:219-229.

27.  Aboulghar M, Somigliana CB, Diczfalusy E, et al. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update. 2009;15:265-277.

28.  Kimberly L, Case A, Cheung AP, et al. Advanced reproductive age and fertility: no. 269, November 2011. Int J Gynaecol Obstet. 2012;117:95-102.

29.  Liu PY, Handelsman DJ. The present and future state of hormonal treatment for male infertility. Hum Reprod Update. 2003;9:9-23.

30.  Bharti S, Misro MM, Rai U. Clomiphene citrate potentiates the adverse effects of estrogen on rat testis and down-regulates the expression of steroidogenic enzyme genes. Fertil Steril. 2013;99:140-148.

31.  Santen RJ. Feedback control of luteinizing hormone and follicle-stimulating hormone secretion by testosterone and estradiol in men: physiological and clinical implications. Clin Biochem. 1981;14:243-251.

32.  Pavlovich CP, King P, Goldstein M, et al. Evidence of a treatable endocrinopathy in infertile men. J Urol. 2001;165:837-841.

33.  National Institute for Health and Care Excellence. Fertility: assessment and treatment for people with fertility problems. February 2013. http://www.rcog.org.uk (last accessed 28 October 2016).

34.  Cayan S, Shavakhabov S, Kadioglu A. Treatment of palpable varicocele in infertile men: a meta-analysis to define the best technique. J Androl. 2009;30:33-40.

35.  Ficarra V, Cerruto MA, Liguori G, et al. Treatment of varicocele in subfertile men: The Cochrane Review - a contrary opinion. Eur Urol. 2006;49:258-263.

36.  Madgar I, Weissenberg R, Lunenfeld B, et al. Controlled trial of high spermatic vein ligation for varicocele in infertile men. Fertil Steril. 1995;63:120-124.

37.  Kroese AC, de Lange NM, et al. Surgery or embolization for varicoceles in subfertile men. Cochrane Database Syst Rev. 2012;10:CD000479.

38.  Schauer I, Madersbacher S, Jost R, et al. The impact of varicocelectomy on sperm parameters: a meta-analysis. J Urol. 2012;187:1540-1547.

39.  Weedin JW, Khera M, Lipshultz LI. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol. 2010;183:2309-2315.

40.  Baazeem A, Belzile E, Ciampi A, et al. Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol. 2011;60:796-808.

41.  Diegidio P, Jhaveri JK, Ghannam S, et al. Review of current varicocelectomy techniques and their outcomes. BJU Int. 2011;108:1157-1172.

42.  Custers IM, van Rumste MM, van der Steeg JW, et al. Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management and immediate treatment. Hum Reprod. 2012;27:444-450.

43.  Zhang XY. Carnitine in the treatment of idiopathic asthenozoospermia: a systematic review. Chin J Evid Based Med. 2009;9:337-345.

44.  Attia AM, Al-Inany HG, Farquhar C, et al. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev. 2007;(4):CD005071.

45.  Attia AM, Abou-Setta AM, Al-Inany HG. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev. 2013;(8):CD005071.

46.  Tonguc E, Var T, Onalan G, et al. Comparison of the effectiveness of single versus double intrauterine insemination with three different timing regimens. Fertil Steril. 2010;94:1267-1270.

47.  Colpi GM, Colpi EM, Piediferro G, et al. Microsurgical TESE versus conventional TESE for ICSI in non-obstructive azoospermia: a randomized controlled study. Reprod Biomed Online. 2009;18:315-319.

48.  Cissen M, Bensdorp A, Cohlen BJ, et al. Assisted reproductive technologies for male subfertility. Cochrane Database Syst Rev. 2016;(2):CD000360.

49.  Boomsma CM, Heineman MJ, Cohlen BJ, et al. Semen preparation techniques for intrauterine insemination. Cochrane Database Syst Rev. 2004;(4):CD004507.

50.  Van Peperstraten A, Proctor ML, Johnson NP, et al. Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI) for azoospermia. Cochrane Database Syst Rev. 2008;(2):CD002807.

51.  Allen VM, Wilson RD, Cheung A; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC); Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC). Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006;28:220-250.

52.  Davies MJ, Moore VM, Willson KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med. 2012;366:1803-1813.

53.  Pashayan N, Lyratzopoulos G, Mathur R. Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility. BMC Health Serv Res. 2006;6:80.

54.  Pandian Z, Marjoribanks J, Ozturk O, et al. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev. 2013;(7):CD003416.

55.  Grady R, Alavi N, Vale R, et al. Elective single embryo transfer and perinatal outcomes: a systematic review and meta-analysis. Fertil Steril. 2012;97:324-331.

56.  Rimm AA, Katayama AC, Katayama KP. A meta-analysis of the impact of IVF and ICSI on major malformations after adjusting for the effect of subfertility. J Assist Reprod Genet. 2011;28:699-705.

57.  Tournaye H. Evidence-based management of male subfertility. Curr Opin Obstet Gynecol. 2006;18:253-259.

58.  Kumar R, Gautam G, Gupta NP. Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol. 2006;176:1307-1312.

59.  Dankert T, Kremer JA, Cohlen BM, et al. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Hum Reprod. 2007;22:792-797.

60.  Bhattacharya S, Harrild K, Mollison J, et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ. 2008;337:a716.

61.  Showell MG, Mackenzie-Proctor R, Brown J, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2014;(12):CD007411.

62.  Safarinejad MR. Effect of pentoxifylline on semen parameters, reproductive hormones, and seminal plasma antioxidant capacity in men with idiopathic infertility: a randomized double-blind placebo-controlled study. Int Urol Nephrol. 2011;43:315-328.

63.  Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009;91:1785-1792.

64.  Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol. 2009;182:237-248.

65.  Safarinejad MR, Safarinejad S, Shafiei N, et al. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. J Urol. 2012;188:526-531.

66.  Safarinejad MR, Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol. 2009;181:741-751.

67.  Ciftci H, Verit A, Savas M, et al. Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. Urology. 2009;74:73-76.

68.  Van Voorhis BJ, Barnett M, Sparks AE, et al. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization. Fertil Steril. 2001;75:661-668.

69.  Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol. 2005;174:1819-1822.

70.  Peng X, Zeng X, Peng S, et al. The association risk of male subfertility and testicular cancer: a systematic review. PLoS One. 2009;4:e5591.

使用此内容应接受我们的免责声明